Company intelligence / Profile preview

Extracellular

Bristol, England, United Kingdomsciencedirect.com ↗

Ownership: Private
Employees: ~35
Development stage: Commercial

Overview

Extracellular is a leading UK-based CDMO providing R&D, process development, scale-up, and manufacturing services to companies developing cultivated meat and other sustainable bio-based products. The company leverages expertise in cell biology, digitalization of bioprocesses, and large-scale bioreactor operations to accelerate commercialization of real meat alternatives. It has grown rapidly since its founding in 2022–2023.

Modalities: Cell therapy (for cultivated meat/food applications)Biologic (cell-based products for food/materials)
Industry: Non-Drug Biotech

Partnerships

University of Bath (Cellular Agriculture Manufacturing Hub)Bristol Bio Engineering Department

Beyond the preview

Go deeper on Extracellular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular.

Explore the full profile